Reply to Xie et al. about the article " Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis"

Joint Bone Spine

Volumn 80, Issue 1, 2013, Pages 117-118

  Talabot Ayer, Dominique ^a,b   Gabay, Cem ^a,b   Palmer, Gaby ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; INTERLEUKIN 33; RHEUMATOID FACTOR;

DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; LETTER; OSTEOARTHRITIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SERUM; SYNOVIAL FLUID;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INTERLEUKINS; MALE; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 84872854406     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.10.007     Document Type: Letter

References (6)

1. Han G.W., Zeng L.W., Liang C.X., et al. Serum levels of IL-33 is increased in patients with ankylosing spondylitis. Clin Rheumatol 2011, 30:1583-1588.
2. Hong Y.S., Moon S.J., Joo Y.B., et al. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011, 26:1132-1139.
3. Matsuyama Y., Okazaki H., Hoshino M., et al. Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1beta signaling and a poor clinical response. Rheumatol Int 2012, 32:1397-1401.
4. Kageyama Y., Torikai E., Tsujimura K., et al. Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33. Mod Rheumatol 2012, 22:89-93.
5. Mu R., Huang H.Q., Li Y.H., et al. Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol 2010, 37:2006-2013.
6. Matsuyama Y., Okazaki H., Tamemoto H., et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol 2010, 37:18-25.